Femasys Inc. (NASDAQ: FEMY) (the "Company” or "Femasys”), a leading biomedical innovator addressing significant unmet needs ...

Femasys intends to use the net proceeds from the public offering and private placement for expansion of commercial efforts, ...

The gross proceeds of the public offering and private placement to Femasys, before deducting the underwriting and placement agent discounts and commissions and other public offering and private ...

All of the securities in the public offering and private placement are being offered by Femasys. The public offering and private placement are subject to market conditions, and there can be no ...

has priced an underwritten public offering of 3.6 million common stock shares at $0.85 per share. In addition, the company is conducting a concurrent private placement of 1,686,275 shares ...

The Concurrent Private Placement is subject to the closing of the public offering and other customary closing conditions. Senseonics intends to use the net proceeds from the public offering and ...

The Concurrent Private Placement is expected to close on May 21, 2025, subject to the closing of the public offering and other customary closing conditions.

The ADS Borrower or its affiliate received all of the proceeds from the sale of the Borrowed ADSs. The Company did not receive any proceeds from the Delta Placement of Borrowed ADSs but received from ...

Centuri Holdings shares were down 6% to $18.47 after the pricing of a previously announced underwritten secondary public offering of nine million company shares by Southwest Gas Holdings as selling ...